VVOS May 2024 2.500 put
| Previous Close | 2.2500 |
| Open | N/A |
| Bid | 0.0000 |
| Ask | 0.0000 |
| Strike | 2.50 |
| Expire Date | 2024-05-17 |
| Day's Range | 2.2500 - 2.2500 |
| Contract Range | N/A |
| Volume | |
| Open Interest | 1 |
- GuruFocus.com
Vivos Therapeutics Inc (VVOS) Q1 2024 Earnings Call Transcript Highlights: Navigating ...
Despite a slight revenue dip, Vivos Therapeutics Inc (VVOS) showcases strategic advancements and operational efficiencies in the first quarter of 2024.
GlobeNewswireVivos Therapeutics Reports First Quarter 2024 Financial Results and Provides Operational Update
Vivos Expanding its Revenue Generating InitiativesAs Operating Expenses Decrease 22%, Representing Seven Consecutive Quarters ofYear Over Year Improvement Due to Successful Cost Cutting Initiatives Management to Host Conference Call Today at 5:00 pm ET LITTLETON, Colo., May 14, 2024 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos” or the “Company’’) (NASDAQ: VVOS), a leading medical device and technology company specializing in the development and commercialization of highly effective propr
- GlobeNewswire
Vivos Therapeutics Schedules Release of First Quarter 2024 Financial Results and Conference Call
Call Scheduled for Today, Tuesday, May 14, 2024 at 5:00 pm ETLITTLETON, Colo., May 14, 2024 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos” or the “Company”) (NASDAQ: VVOS), a leading medical device and technology company specializing in the development and commercialization of highly effective proprietary treatments for sleep related breathing disorders (including all severities of obstructive sleep apnea (OSA) in adults), today announced it plans to release its first quarter 2024 financi
